
News
Advertisement


Advertisement




Advertisement















REGULATORY : Is It Safe to Outsource Safety? Waiving Inclusion/Exclusion Criteria CRO/SPONSOR : Metrics - The Pitfalls of Over Collection SUBJECT RECRUITMENT : Trial Results Provided to Volunteers in Pilot Program Also in this issue : New Reform Law Requires Fee Disclosure, GCP Standards in Global Trials, A Learning Healthcare System, The Physician Payments Sunshine Act

Updates on the pian drugs market.

Industry news focusing on the people and organizations who work in the clinical trials profession.


Clinical grant expenditures represent a major portion of the budget for later phase clinical trials.


Knowing when to outsource and when to conduct pharmacovigilance in-house is a crucial decision.


Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
2
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
3
Building More Representative Cancer Trial Populations
4
ACT Brief: Reframing Site Initiation Readiness, Operational Execution as Competitive Advantage, and a Historic Motion Sickness Approval
5